Xing Liu il 26/12/2024

Nuclear Factor Erythroid 2-Related Factor 2 Activator DDO-1039 Ameliorates Podocyte Injury in Diabetic Kidney Disease via Suppressing Oxidative Stress, Inflammation, and Ferroptosis

Antioxid Redox Signal. 2024 Dec 24. doi: 10.1089/ars.2024.0653. Online ahead of print.ABSTRACTAims: Diabetic kidney disease (DKD) is the leading cause of end-stage kidney disease, and podocyte injury is one of the major contributors to DKD. As a crucial transcriptional factor that regulates cellular

Haiyan Gu il 26/12/2024

Exploring the effect and mechanism of action of Jinlida granules (JLD) in the treatment of diabetes-associated cognitive impairment based on network pharmacology with experimental validation

Ann Med. 2025 Dec;57(1):2445181. doi: 10.1080/07853890.2024.2445181. Epub 2024 Dec 26.ABSTRACTOBJECTIVES: To explore the effect and the probable mechanisms of JLD in the treatment of type 2 diabetes mellitus (T2DM) - associated cognitive impairment (TDACI).METHODS: The effect of JLD in combating TDA

Amankeldi A Salybekov il 26/12/2024

Cell therapy in kidney diseases: advancing treatments for renal regeneration

Front Cell Dev Biol. 2024 Dec 11;12:1505601. doi: 10.3389/fcell.2024.1505601. eCollection 2024.ABSTRACTKidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), pose a significant global health challenge, with high morbidity and mortality rates driven by rising prevalenc

Dongliang Lv il 25/12/2024

Neuroprotective effects of GLP-1 class drugs in Parkinson's disease

Front Neurol. 2024 Dec 10;15:1462240. doi: 10.3389/fneur.2024.1462240. eCollection 2024.ABSTRACTParkinson's disease (PD) is a chronic, progressive neurological disorder primarily affecting motor control, clinically characterized by resting tremor, bradykinesia, rigidity, and other symptoms that sign

Hang Yang il 24/12/2024

Insights into renal damage in hyperuricemia: Focus on renal protection (Review)

Mol Med Rep. 2025 Mar;31(3):59. doi: 10.3892/mmr.2024.13424. Epub 2024 Dec 24.ABSTRACTThe incidence of hyperuricemia has increased recently, posing a serious threat to public health. Hyperuricemia is associated with an increased risk of gout, chronic kidney disease (CKD), obesity, metabolic syndrome

Xiangheng Cai il 24/12/2024

A novel self-assembling peptide nanofiber hydrogel with glucagon-like peptide-1 functionality enhances islet survival to improve islet transplantation outcome in diabetes treatment

J Nanobiotechnology. 2024 Dec 23;22(1):792. doi: 10.1186/s12951-024-03072-5.ABSTRACTIslet transplantation is a promising therapy for diabetes, yet the limited survival and functionality of transplanted islet grafts hinder optimal outcomes. Glucagon-like peptide-1 (GLP-1), an endogenous hormone, has

Yuchen Ma il 20/12/2024

Comparison of adverse cardiovascular event endpoints between patients with diabetes and patients without diabetes based on coronary artery plaques: a systematic review and meta-analysis

J Cardiothorac Surg. 2024 Dec 20;19(1):672. doi: 10.1186/s13019-024-03157-0.ABSTRACTBACKGROUND: The classification of major adverse cardiovascular event (MACE) endpoints in patients with type 2 diabetes mellitus (T2DM) and either confirmed coronary artery disease (CAD) or high CAD risk, as well as t